DK1758569T3 - Guanylhydrazonsalte, sammensætninger, fremgangsmåder til fremstilling og fremgangsmåder til anvendelse - Google Patents
Guanylhydrazonsalte, sammensætninger, fremgangsmåder til fremstilling og fremgangsmåder til anvendelseInfo
- Publication number
- DK1758569T3 DK1758569T3 DK05763891.8T DK05763891T DK1758569T3 DK 1758569 T3 DK1758569 T3 DK 1758569T3 DK 05763891 T DK05763891 T DK 05763891T DK 1758569 T3 DK1758569 T3 DK 1758569T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- compositions
- preparation
- guanyl hydrazone
- hydrazone salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58253204P | 2004-06-25 | 2004-06-25 | |
US60199204P | 2004-08-17 | 2004-08-17 | |
US11/165,255 US7244765B2 (en) | 2004-06-25 | 2005-06-24 | Guanylhydrazone salts, compositions, processes of making and methods of using |
PCT/US2005/022626 WO2006004613A2 (en) | 2004-06-25 | 2005-06-27 | Guanylhydrazone salts, compositions, processes of making and methods of using |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1758569T3 true DK1758569T3 (da) | 2013-07-01 |
Family
ID=35600290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05763891.8T DK1758569T3 (da) | 2004-06-25 | 2005-06-27 | Guanylhydrazonsalte, sammensætninger, fremgangsmåder til fremstilling og fremgangsmåder til anvendelse |
Country Status (12)
Country | Link |
---|---|
US (3) | US7244765B2 (da) |
EP (2) | EP2540703B1 (da) |
JP (2) | JP5086072B2 (da) |
CN (1) | CN1968686B (da) |
AU (1) | AU2005260126B2 (da) |
BR (1) | BRPI0511819A (da) |
CA (1) | CA2566648C (da) |
DK (1) | DK1758569T3 (da) |
ES (1) | ES2424356T3 (da) |
PL (1) | PL1758569T3 (da) |
PT (1) | PT1758569E (da) |
WO (1) | WO2006004613A2 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7244765B2 (en) * | 2004-06-25 | 2007-07-17 | Cytokine Pharmasciences, Inc | Guanylhydrazone salts, compositions, processes of making and methods of using |
CN102936212A (zh) * | 2004-08-17 | 2013-02-20 | 辉凌公司 | 脒腙化合物、组合物、制备方法及使用方法 |
CA2655632A1 (en) * | 2006-06-23 | 2008-01-03 | The Feinstein Institute For Medical Research | Inhibitors of a.beta. and synuclein aggregation |
WO2009054994A2 (en) * | 2007-10-23 | 2009-04-30 | President And Fellows Of Harvard College | Sirt-3 related methods and compositions for mimicking exercise |
MX2011003002A (es) * | 2008-09-19 | 2011-05-31 | Cytokine Pharmasciences Inc | Prevención de poi. |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4704397A (en) | 1980-03-11 | 1987-11-03 | Warner-Lambert Company | Pharmaceutical salts of 4-(9-acridinyl-amino) methanesulfon-m-anisidide |
US4321253A (en) | 1980-08-22 | 1982-03-23 | Beatty Morgan L | Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration |
DK161312C (da) | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
DK147640C (da) | 1982-06-11 | 1985-05-06 | Dumex Ltd As | Fremgangsmaade til fremstilling af nitroimidazol-derivater |
US5272165A (en) | 1984-03-19 | 1993-12-21 | The Rockefeller University | 2-alkylidene-aminoguanidines and methods of use therefor |
US4791196A (en) | 1986-09-26 | 1988-12-13 | Sankyo Company Limited | Crystalline cephem carboxylic acid addition salt |
US5690954A (en) | 1987-05-22 | 1997-11-25 | Danbiosyst Uk Limited | Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material |
US5028625A (en) | 1989-06-20 | 1991-07-02 | American Home Products Corporation | Acid addition salt of ibuprofen and meglumine |
US7425543B2 (en) | 1992-11-16 | 2008-09-16 | The Corporation Of Mercer University | Microencapsulated materials and method of making same |
US5599984A (en) | 1994-01-21 | 1997-02-04 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
US6008255A (en) | 1994-01-21 | 1999-12-28 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
US5567592A (en) | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
US5599986A (en) * | 1994-09-29 | 1997-02-04 | Hoechst Marion Roussel Inc. | Process for the preparation of alkali metal salts of diformylamide |
US5993858A (en) | 1996-06-14 | 1999-11-30 | Port Systems L.L.C. | Method and formulation for increasing the bioavailability of poorly water-soluble drugs |
CN1230123A (zh) | 1996-07-11 | 1999-09-29 | 荷兰发马克有限公司 | 含碱性药物的酸加成盐的药物组合物 |
DE69739734D1 (de) | 1996-11-15 | 2010-02-25 | Cytokine Pharmasciences Inc | Guanylhydrazone die nützlich sind zur behandlung von mit t-zellen verbundenen krankheiten |
US6319894B1 (en) * | 1997-01-08 | 2001-11-20 | The Picower Institute For Medical Research | Complexes and combinations of fetuin with therapeutic agents |
FR2758459B1 (fr) | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
FR2760190B1 (fr) | 1997-02-28 | 1999-04-09 | Adir | Composition pharmaceutique pour la liberation programmee de dexfenfluramine |
US6277406B1 (en) * | 1997-10-08 | 2001-08-21 | Fuisz Technologies Ltd. | Easily processed tablet compositions |
CA2643231A1 (en) | 1999-07-01 | 2001-01-11 | Pharmacia & Upjohn Company | Norepinephrine reuptake inhibitors and methods of using the same |
DE60114772T2 (de) | 2000-02-02 | 2006-07-20 | Dorian Bevec | Aromatisches guanylhydrazon zur behandlung resistenter viraler infektionen |
AU2001269092A1 (en) * | 2000-06-27 | 2002-01-08 | Axxima Pharmaceuticals Ag | Inhibitors of hepatitis b virus infection |
CA2775616C (en) | 2000-08-04 | 2013-09-17 | Takeda Pharmaceutical Company Limited | Salts of benzimidazole compound and application thereof |
WO2002058699A1 (en) | 2001-01-25 | 2002-08-01 | Bristol-Myers Squibb Company | Pharmaceutical forms of epothilones for oral administration |
EP1397160A1 (en) | 2001-04-30 | 2004-03-17 | Shire Laboratories Inc. | Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
US20030198669A1 (en) | 2001-07-05 | 2003-10-23 | R.T. Alamo Ventures I, Llc | Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine |
WO2003006426A1 (en) * | 2001-07-13 | 2003-01-23 | Axxima Pharmaceuticals Ag | Aromatic guanylhydrazones as effective compounds against neurodiseases |
WO2003024407A2 (en) | 2001-09-21 | 2003-03-27 | Message Pharmaceuticals, Inc. | Inhibitors of rnase p proteins as antibacterial compounds |
US6689777B2 (en) | 2001-10-23 | 2004-02-10 | Kenneth S. Warren Institute | Anti-malarial compounds, compositions and methods |
MXPA04005210A (es) | 2001-11-29 | 2004-08-19 | Schering Corp | Procedimiento para la preparacion de composiciones que tienen una cantidad incrementada de sales farmaceuticamente activas de rotameros. |
CN100436449C (zh) | 2001-11-29 | 2008-11-26 | 先灵公司 | 作为ccr5-拮抗剂用于治疗aids和相关的hiv感染的药用盐的制备 |
CA2476896A1 (en) * | 2002-02-26 | 2003-09-04 | North Shore-Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
GB0207104D0 (en) | 2002-03-26 | 2002-05-08 | Pfizer Ltd | Stable hydrate of a muscarinic receptor antagonist |
EP1389480A1 (en) * | 2002-08-14 | 2004-02-18 | Mondobiotech Interferon SA | Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation |
US7244765B2 (en) | 2004-06-25 | 2007-07-17 | Cytokine Pharmasciences, Inc | Guanylhydrazone salts, compositions, processes of making and methods of using |
US7795314B2 (en) * | 2005-06-01 | 2010-09-14 | Cytokine Pharmasciences, Inc. | Protective role of semapimod in necrotizing enterocolitis |
-
2005
- 2005-06-24 US US11/165,255 patent/US7244765B2/en active Active
- 2005-06-27 ES ES05763891T patent/ES2424356T3/es active Active
- 2005-06-27 EP EP12185925.0A patent/EP2540703B1/en not_active Not-in-force
- 2005-06-27 CN CN2005800202394A patent/CN1968686B/zh active Active
- 2005-06-27 EP EP05763891.8A patent/EP1758569B1/en active Active
- 2005-06-27 AU AU2005260126A patent/AU2005260126B2/en active Active
- 2005-06-27 PT PT57638918T patent/PT1758569E/pt unknown
- 2005-06-27 WO PCT/US2005/022626 patent/WO2006004613A2/en not_active Application Discontinuation
- 2005-06-27 CA CA2566648A patent/CA2566648C/en active Active
- 2005-06-27 DK DK05763891.8T patent/DK1758569T3/da active
- 2005-06-27 JP JP2007518339A patent/JP5086072B2/ja active Active
- 2005-06-27 PL PL05763891T patent/PL1758569T3/pl unknown
- 2005-06-27 BR BRPI0511819-0A patent/BRPI0511819A/pt not_active Application Discontinuation
-
2007
- 2007-06-22 US US11/766,794 patent/US8034840B2/en active Active
- 2007-10-31 US US11/931,738 patent/US8497306B2/en active Active
-
2012
- 2012-02-20 JP JP2012034131A patent/JP5576416B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
PT1758569E (pt) | 2013-08-23 |
JP2012121905A (ja) | 2012-06-28 |
WO2006004613A2 (en) | 2006-01-12 |
JP5576416B2 (ja) | 2014-08-20 |
EP2540703A1 (en) | 2013-01-02 |
PL1758569T3 (pl) | 2013-10-31 |
US20080262090A1 (en) | 2008-10-23 |
AU2005260126A1 (en) | 2006-01-12 |
US20060014833A1 (en) | 2006-01-19 |
US8497306B2 (en) | 2013-07-30 |
EP1758569A2 (en) | 2007-03-07 |
CN1968686A (zh) | 2007-05-23 |
US20080146670A1 (en) | 2008-06-19 |
AU2005260126B2 (en) | 2012-04-19 |
EP1758569B1 (en) | 2013-05-08 |
US7244765B2 (en) | 2007-07-17 |
JP5086072B2 (ja) | 2012-11-28 |
BRPI0511819A (pt) | 2007-12-26 |
CN1968686B (zh) | 2013-01-16 |
ES2424356T3 (es) | 2013-10-01 |
US8034840B2 (en) | 2011-10-11 |
EP2540703B1 (en) | 2015-05-27 |
CA2566648C (en) | 2013-04-02 |
CA2566648A1 (en) | 2006-01-12 |
EP1758569A4 (en) | 2010-01-20 |
JP2008504288A (ja) | 2008-02-14 |
WO2006004613A3 (en) | 2006-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2017017I1 (no) | umeklinidium og vilanterol | |
DK1756064T3 (da) | Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder | |
DK1713806T3 (da) | Forbindelser og sammensætninger som proteinkinaseinhibitorer | |
DK1765327T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
DK1924577T3 (da) | Substituerede benzimidazoler og fremgangsmåder til fremstilling | |
DK1723135T3 (da) | Kendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som pde4-inhibitorer | |
NO20055686L (no) | Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav. | |
DK1648426T3 (da) | Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer | |
DK1996557T3 (da) | Pyridazinon-forbindelse og anvendelse deraf som herbicid | |
DK1913001T3 (da) | (r)-n-methylnaltrexon, fremgangsmåder til syntese og farmaceutisk anvendelse heraf | |
DK1922309T3 (da) | N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf | |
DK1877379T3 (da) | Hydroxybenzamidderivater og anvendelse heraf som inhibitorer af hsp90 | |
DK1931645T3 (da) | N-(3-aminoquinoxalin-2-yl)-sulfonamidderivater og deres anvendelse som inhibitorer af phosphatidylinositol-3-kinase | |
DK1948695T3 (da) | Immunogene sammensætninger og fremgangsmåder til andvendelse | |
IS7966A (is) | Pyrazól og aðferðir við að búa þau til og notkun þeirra | |
DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
DK1928840T3 (da) | 1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer | |
DK1761529T3 (da) | Pyrrolopyridinderivater og deres anvendelse som CRTh2-antagonister | |
DK1830926T3 (da) | Oreganomundplejesammensætninger og fremgangsmåde til anvendelse heraf | |
DK2038275T3 (da) | Ny pyridazinforbindelse og anvendelse heraf | |
DK2019090T3 (da) | Substitueret beta-phenyl-alfa-hydroxypropansyre, fremgangsmåde til syntese og anvendelse deraf | |
DK2617714T3 (da) | Kemiske derivater af jasmonat, farmaceutiske præparater og fremgangsmåder til anvendelse deraf | |
DK1831237T3 (da) | Amidprolægemiddel af gemcitabin, sammensætninger og anvendelse deraf | |
DK2069467T3 (da) | Adskillende sammensætninger og fremgangsmåder til anvendelse | |
NO20082256L (no) | Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse |